Related Experiment Video
Updated: Jul 1, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Significance of Borrelia infection in development of dilated cardiomypathy (a pilot study)
P Bartůnĕk1, K Gorican, T Veiser
1Charles University in Prague, First Faculty of Medicine and General Teaching Hospital, Fourth Department of Internal Medicine, Prague, Czech Republic. petr.bartunek@lf1.cuni.cz
Insights
Borrelia infection likely contributes to dilated cardiomyopathy (DCMP), a rare heart condition. This study investigated Lyme borreliosis (LB) in DCMP patients, finding probable etiological links.
Area of Science:
- Cardiology
- Infectious Diseases
- Myocardial Diseases
Background:
- Lyme carditis (LC), a manifestation of Lyme borreliosis (LB), is rare, accounting for <4% of LB cases in Europe.
- Diagnosis of LC presents significant challenges, with AV blocks common in the US and arrhythmias prevalent in the Czech Republic.
- Dilated cardiomyopathy (DCMP) is an exceptionally rare form of LC, with controversial etiological links to Borrelia infection.
Purpose of the Study:
- To investigate the etiological role of Borrelia infection in the development of dilated cardiomyopathy (DCMP).
- To explore the controversial link between Borrelia burgdorferi sensu lato (Bb) and DCMP.
- To identify diagnostic markers for Borrelia infection in patients with DCMP.
Main Methods:
- Study enrolled 33 DCMP patients (23 males, 10 females; mean age 57.7 years).
- Borrelia infection (BI) detected via ELISA, confirmed by Western blot, and pathogen DNA identified using PCR.
- Myocardial biopsy samples examined via electron microscopy for Spirochaetae detection.
Main Results:
- 17 patients (3 females, 13 males; mean age 58 years) confirmed with Borrelia burgdorferi (Bb) presence.
- Bb presence confirmed by PCR identification of DNA or electron microscopic detection of Spirochaetae in myocardial tissue.
- Findings strongly suggest Borrelia infection's probable participation in DCMP development.
Conclusions:
- Borrelia infection is a likely contributing factor in the development of dilated cardiomyopathy.
- Many DCMP cases linked to Borrelia may stem from subclinical or inadequately treated cutaneous LB forms.
- Further research is warranted to understand the mechanisms of Borrelia-induced cardiomyopathy.
Abstract:
A heart involvement known as Lyme carditis (LC), a consequence of Lyme borreliosis (LB), is relatively rare in contrast to the involvement of skin, joints and nervous system; it accounts for < 4% of all these patients in European countries. However, the diagnosis of the disease belongs to the most difficult challenges. While various forms of AV blocks dominate in the USA as confirmed by the literature, there is a clear predominance of arrhythmias of various incidence in the Czech Republic. The authors of this article focused on the form belonging to the rarest manifestations of LC, namely dilated cardiomyopathy (DCMP). The goal was to elucidate the etiological participation of Borrelia infection in the development of DCMP, which has attracted controversial opinions so far. In total, 33 patients with DCMP were enrolled in the study, 23 males and 10 females, with mean age 57.7 years (range 24-76 years). ELISA NRLB KC 90 method was used in all blood samples for detection of Borrelia infection (BI), Western blot method was used for confirmation, followed by identification of DNA of pathogenic Borreliae using PCR method. Bioptic material was examined by electronmicroscopy with an attempt to detect Spirochaetae in myocardium. 16 patients were excluded from the study owing to the absence of signs of LB. The study group included 17 patients (3 females, 13 males) with mean age 58 years (range 43-76 years), in whom the presence of Bb was proved by identification of DNA of pathogenic Borreliae or by electronmicroscopic detection of Spirochetae in myocardial bioptic sample. The findings obtained during the study confirmed that BI very probably participated in the development of dilated cardiomyopathy. It may be concluded that most of cases were either unapparent forms of LB or insufficiently treated cutaneous forms of this disease.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy IV: Restrictive Cardiomyopathy
